Skip to main content
Navigate Up
Sign In

Your Health: New chemical compound targets leukemia stem cells

Oncologist Dan Pollyea did have one option: an FDA approved clinical trial testing a low dose chemo combined with the pill venetoclax, a drug that targets leukemia stem cells. “We’ve never seen a drug work like this, to target any type of cancer cell, let alone a stem cell,” said Pollyea, Clinical director of Leukemia Services at the University of Colorado's Cancer Center at the Anschutz Medical Campus.

WQAD (Moline, Ill.), Nov. 1, 2019

Read more